--- title: "Kintor Pharma falls 6% in Hong Kong trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/305900969.md" description: "Kintor Pharma fell 6.21% to HK$1.360. Down 51.25% over six months and down 30.61% YTD." datetime: "2026-11-18T02:13:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/305900969.md) - [en](https://longbridge.com/en/news/305900969.md) - [zh-HK](https://longbridge.com/zh-HK/news/305900969.md) generator: "portal-rs" --- # Kintor Pharma falls 6% in Hong Kong trading Kintor Pharma (9939.HK) fell more than **6%** in Hong Kong trading, last at **HK$1.360**. The stock is down 51.25% over the past six months and down 30.61% year to date. It sits 71.06% below its 52-week high of HK$4.700. The Hang Seng Index is down 3.82% over the past five sessions and down 8.75% year to date. The biotechnology industry index fell 2.1% over the same period. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [09939.HK](https://longbridge.com/en/quote/09939.HK.md) ## Related News & Research - [Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 million](https://longbridge.com/en/news/296370818.md) - [Kintor Pharma completes 52-week human safety trial of skin-whitening ingredient KT-939](https://longbridge.com/en/news/298141186.md) - [Public Power Corporation S.A. Just Missed Revenue By 7.1%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/306350012.md) - [Concerns Surrounding Srinibas Pradhan Constructions' (NSE:SPCON) Performance](https://longbridge.com/en/news/306347727.md) - [Tamil Nadu Newsprint and Papers' (NSE:TNPL) Profits Appear To Have Quality Issues](https://longbridge.com/en/news/306343812.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**